Mail & Guardian (Johannesburg) - September 14, 2001
Vaccine hope? Scientists attending a conference focused on the creation of a vaccine against HIV say they are more hopeful than ever that a vaccine will be developed - but that it is likely to take at least a decade. There has been a scattering of preliminary positive results, such as monkeys given a trial vaccine that have so far survived for more than 600 days lethal doses of simian HIV.
Call to action: Leading medical journals have acccused the pharmaceutical industry of interfering in human clinical trials of new drugs, and have called for greater independence of such research.
Breast may not be best: If HIV-positive pregnant women stop breastfeeding and take anti- retroviral drugs that counter the transmission of the virus, the infection rates in babies could be cut by 70% to 80%
Sources: www.redribbon.co.za, other news organisations
010914
MG010904
Copyright © 2001 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.
ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2000. ÆGIS. All materials appearing on ÆGIS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS, or the party credited as the provider of the content. Feedback/Contact Us.